CATALAYER NEWS
Novartis DM1 drug fails late-stage trial, clouding development outlook
Source: Investing.com · 2026-09-08
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Exclusive-China’s AI chipmakers raise prices as high-bandwidth memory shortage bites
2026-09-10
HIVE Digital appoints Mark Volk as revenue chief at BUZZ HPC unit
2026-09-10
Axe Compute director Theodore Zhu buys $98,325 shares
2026-09-10
Portugal debt upgrade seals PIIGS passage from pariahs to pin-ups
2026-09-10
FDA grants priority review for Enspryng in rare disease MOGAD
2026-09-10
RELATED ON CATALAYER
Mentioned Tickers
$NVS · NovartisRELATED MARKETS
Prediction Markets